NHS at breaking point: when politics sells out public health

Britain’s healthcare system is being hollowed out—not by a virus, but by a government that treats public health as a bargaining chip. This week, the NHS became the latest casualty of Westminster’s quiet surrender to corporate interests, with Keir Starmer’s administration pushing through a US pharma deal that could drain £45bn from frontline services and cost 229,000 lives. Meanwhile, women’s health remains a postcode lottery, maternity care is being rewritten behind closed doors, and the political class is too busy celebrating its own pragmatism to notice the bodies piling up.

The £45bn question: who pays for Starmer’s trade gamble?

The US-UK medicine import deal, agreed last December and rammed through parliament this week, was sold as a win for British patients. In reality, it’s a Trojan horse. Independent analysis suggests the NHS will be forced to divert £45bn from essential services—doctors, nurses, cancer scans—to pay for inflated US drug prices. The human cost? An estimated 229,000 excess deaths in England alone.

Ministers claim the deal will give patients access to life-extending drugs. But at what price? The NHS is already stretched to breaking point, with waiting lists at record highs and trusts forced to ration care. Diverting billions to Big Pharma won’t just delay treatments—it will actively kill people. And yet, the government has refused to publish a full impact assessment. Why? Because the numbers don’t add up to a success story.

This isn’t just bad policy—it’s a democratic failure. Starmer’s team is acting against the public, not for it. The deal was negotiated in secret, debated in haste, and passed without proper scrutiny. When politicians prioritise trade optics over human lives, they’re not governing—they’re gambling with people’s futures.

Maternity care: when ideology trumps safety

While the pharma deal dominates headlines, another crisis is unfolding in silence. The government-commissioned review of England’s maternity services, led by Valerie Amos, was supposed to be a reckoning. Instead, it’s become a case study in how institutional bias distorts policy.

Dr Bill Kirkup, one of the review’s expert advisers, has accused Amos of bowing to pressure to remove criticism of “normal birth ideology”—the push for vaginal deliveries at all costs. The section, which reportedly warned of the risks of this approach, “disappeared” from the final report. Kirkup’s verdict? “She listened to the wrong voices.”

This isn’t just about one report. It’s about a system that still treats women’s pain as an afterthought. The same week the review was published, new NICE guidelines recommended yearly NHS checks for women with polycystic ovary syndrome (PCOS)—a condition affecting millions that remains under-diagnosed and inconsistently managed. Why did it take this long? Because women’s health has never been a priority.

The message is clear: when ideology clashes with safety, ideology wins. And women pay the price.

The quiet crisis: women’s health as a postcode lottery

PCOS isn’t the only condition being ignored. From endometriosis to menopause, women’s health in Britain is a patchwork of neglect. NICE’s new guidelines are a step forward, but they won’t fix the deeper problem: a system that treats women’s bodies as an inconvenience.

The NHS is supposed to be universal. In practice, it’s a lottery. Where you live determines whether you get diagnosed, treated, or dismissed. This isn’t just about funding—it’s about culture. A system that still debates whether “normal birth” is more important than safety is a system that hasn’t reckoned with its own biases.

And while politicians haggle over drug prices and trade deals, the real work of healthcare—listening to patients, trusting evidence, prioritising safety—gets lost in the noise.

What’s left when the system fails?

The NHS isn’t just a service. It’s a promise: that when you’re sick, when you’re scared, when you’re bringing a child into the world, someone will be there to help. This week, that promise was broken.

The US pharma deal will cost lives. The maternity care review was watered down. Women with PCOS are still fighting for basic recognition. And the government? It’s too busy patting itself on the back for a trade deal that will bleed the NHS dry.

This isn’t a healthcare crisis. It’s a political one. And until someone in Westminster starts treating public health as more than a bargaining chip, the bodies will keep piling up.